Osteoarthritis Symptoms? - Get Relief with Custom-Made Vitamins & Herbs Now

Latest Health Related News:
FDA Accepts Sucampo's SNDA For Lubiprostone (8 Mcg) For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)
Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP) announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA). Sucampo Pharmaceuticals currently anticipates a decision from the FDA in the second quarter of 2008.
New Insights Into Adult Rhinosinusitis
Acute bacterial rhinosinusitis in adults is a common malady, with between 30 to 35 million cases a year. These patients are seen by a range of practitioners, from primary care physicians to otolaryngologists. Findings from a meta-analysis that examined the use of antibiotics for treatment of these patients are presented at the 2007 AAO-HNSF Annual Meeting & OTO EXPO.
Men Who Learn More About PSA Test Are Less Likely To Seek Screening
When men get a little extra help in understanding prostate cancer screening tests, they come away more educated and confident about their choices. However, they might also be less likely to go ahead with the tests, according to a closer look at some recent studies.More than 6,000 men took part in the studies, which looked at the effects of "decision aids" such as pamphlets, videotaped programs and Web sites that discussed the pros and cons of prostate cancer screening.